|
World News |
|
Ocular Surgery News
|
The Voice of Ophthalmology - latest news and articles from Ocular Surgery News; Ophthalmic Surgery, Lasers and Imaging; Journal of Refractive Surgery; and Pediatric Ophthalmology and Strabismus
|
|
-
Conjunctiva may aid in assessment of glaucoma-induced pathologic modifications
Conjunctival microcysts were found in all hypertensive and glaucomatous eyes in a study, leading researchers to believe that the conjunctiva could be a potential target tissue for in vivo microscopic investigation of glaucoma-induced pathologic modifications.
-
Genentech shareholders file lawsuit over Roche's proposed buyout
NEW YORK — A Genentech shareholder has filed a lawsuit on behalf of other Genentech investors concerning the company's proposed buyout by Roche, its majority shareholder, according to a press release from Cohen, Milstein, Hausfeld & Toll, legal counsel for the plaintiff.
-
Tranexamic acid does not seem to lower rebleed rate in pediatric traumatic hyphema
Treating children with traumatic hyphema with tranexamic acid plus topical steroids does not appear to significantly lower the incidence of rebleed compared to treatment with topical steroids alone, a retrospective study suggests.
-
Pseudophakic corneal edema remains most common indication for PK
Pseudophakic corneal edema remains the most common indication for penetrating keratoplasty, according to a retrospective chart review by researchers in Pennsylvania.
-
Genentech forms special committee to review Roche's buyout proposal
SOUTH SAN FRANCISCO, Calif. — Genentech has formed a special committee composed of its three independent directors to assess Roche's proposal to purchase all of the outstanding shares of company's stock that it does not already own, Genentech announced in a press release.
-
Two STAAR lenses receive NTIOL designation from CMS
MONROVIA, Calif. STAAR Surgical has announced that two of its aspheric IOLs have received new technology IOL designation from the Centers for Medicare and Medicaid Services, the company announced in a press release.
-
Canadian Bio Med Systems to acquire licensing rights for AMD, glaucoma drugs
MONTREAL Canadian Bio Med Systems has signed a preliminary agreement for the licensing rights to two new drugs with ophthalmic indications from Ocular Therapeutics., Canadian Bio Med Systems announced in a press release.
-
Welcome to the OSN SuperSite Podcasts
Stay-tuned directly through your computer, or anywhere you go with your portable MP3 device. Podcasts offer a unique way to fit daily news into your busy schedule.
-
Merck posts $6.1 billion in global sales in second quarter
WHITEHOUSE STATION, N.J Merck reported $6.1 billion in worldwide sales for the second quarter, representing a 1% decline compared with sales from the same period in 2007, the company announced in a press release. Specifically, foreign exchange favorably affected global sales by 5% for the quarter, the release said.
-
Alcon posts 17.9% rise in second quarter sales
HUENENBERG, Switzerland Alcon reported global sales of $1.74 billion for the second quarter, an increase of 17.9% compared with global sales for the second quarter of 2007, or 11.2% excluding the impact of foreign exchange fluctuations, the company announced in a press release.
-
Study identifies transporter protein responsible for delivering carotenoids to RPE cells
Retinal pigment epithelial cells appear to preferentially accumulate the xanthophylls lutein and zeaxanthin over beta-carotene by a process that is dependent on the protein SR-BI, according to a study.
|
|